Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/analysis-of-btk-mutations-in-patients-with-x-linked-Kg1oWkb9PI
References (48)
-
Sangita Mukhopadhyay, A. George, V. Bal, Balachandran Ravindran, S. Rath (1999)
Bruton's tyrosine kinase deficiency in macrophages inhibits nitric oxide generation leading to enhancement of IL-12 induction.Journal of immunology, 163 4
-
P. Rutland, L. Pulleyn, W. Reardon, M. Baraitser, R. Hayward, B. Jones, S. Malcolm, R. Winter, M. Oldridge, S. Slaney, M. Poole, A. Wilkie (1995)
Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypesNature Genetics, 9
-
M. Vihinen, D. Vetrie, H. Maniar, H. Ochs, Qili Zhu, I. Vořechovský, A. Webster, L. Notarangelo, L. Nilsson, J. Sowadski (1994)
Structural basis for chromosome X-linked agammaglobulinemia: a tyrosine kinase disease.Proceedings of the National Academy of Sciences of the United States of America, 91 26
-
S. Tsukada, D. Saffran, D. Rawlings, O. Parolini, R. Allen, I. Klisak, R. Sparkes, H. Kubagawa, T. Mohandas, S. Quan, J. Belmont, M. Cooper, M. Conley, O. Witte (1993)
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemiaCell, 72
-
Janet Siliciano, Theresa Morrow, Stephen Desiderio (1992)
itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2.Proceedings of the National Academy of Sciences of the United States of America, 89 23
-
H. Gaspar, T. Lester, R. Levinsky, C. Kinnon (1998)
Analysis of Bruton's tyrosine kinase protein expression and activity in patients with X-linked agammaglobulinemia (XLA):the use of protein analysis as a diagnostic indicator of XLA -
K. Dipple, E. Mccabe (2000)
Phenotypes of patients with "simple" Mendelian disorders are complex traits: thresholds, modifiers, and systems dynamics.American journal of human genetics, 66 6
-
K. Sato, H. Mano, T. Ariyama, J. Inazawa, Y. Yazaki, H. Hirai (1994)
Molecular cloning and analysis of the human Tec protein-tyrosine kinase.Leukemia, 8 10
-
Bolen (1993)
Nonreceptor tyrosine kinasesOncogene, 8
-
Shoji Hashimoto, Akihiro Iwamatsu, Masamichi Ishiai, K. Okawa, T. Yamadori, M. Matsushita, Yoshihiro Baba, Tadamitsu Kishimoto, Tomohiro Kurosaki, Satoshi Tsukada (1999)
Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK--functional significance of Btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling.Blood, 94 7
-
M. Vihinen, S. Kwan, T. Lester, H. Ochs, Igor Resnick, J. Väliaho, M. Conley, C.I. Smith (1999)
Mutations of the human BTK gene coding for bruton tyrosine kinase in X‐linked agammaglobulinemiaHuman Mutation, 13
-
C. Smith, B. Baskin, P. Humire-Greiff, J. Zhou, P. Olsson, H. Maniar, P. Kjellén, John Lambris, Birger Christensson, Lennart Hammarström (1994)
Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells.Journal of immunology, 152 2
-
M. Weers, M. Verschuren, M. Kraakman, R. Mensink, R. Schuurman, J. Dongen, R. Hendriks (1993)
The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stagesEuropean Journal of Immunology, 23
-
B. Saha, S. Curtis, L. Vogler, M. Vihinen (1997)
Molecular and Structural Characterization of Five Novel Mutations in the Bruton’s Tyrosine Kinase Gene from Patients with X-Linked AgammaglobulinemiaMolecular Medicine, 3
-
R. Brooimans, Adrienne Berg, Ger Rijkers, M. LiekeA, K. SandersJohannes, Marcel Amstel, Marina Tilanus, Grubben, Netherlands Brooimans, AJAMvan Berg, L. Sanders, J. Zegers, Dna Laboratory, The Utrecht, K. NetherlandsJ, P. Amstel, J. UtrechtG, Tilanus, L. NijmegenJA (1997)
Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia.Journal of Medical Genetics, 34
-
D. Vetrie, I. Vořechovský, P. Sideras, P. Sideras, J. Holland, A. Davies, F. Flinter, L. Hammarström, C. Kinnon, R. Levinsky, M. Bobrow, C. Smith, D. Bentley (1993)
The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinasesNature, 361
-
S. Kornfeld, R. Haire, S. Strong, Emerita Brigino, Huayang Tang, Sun-Sang Sung, Shu Fu, G. Litman (1997)
Extreme variation in X-linked agammaglobulinemia phenotype in a three-generation family.The Journal of allergy and clinical immunology, 100 5
-
Y. Kawakami, J. Kitaura, D. Hata, L. Yao, T. Kawakami (1999)
Functions of Bruton's tyrosine kinase in mast and B cellsJournal of Leukocyte Biology, 65
-
P. Chomczyński, N. Sacchi (1987)
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Analytical biochemistry, 162 1
-
Dean (1994)
Heterogeneity in the severity of cystic fibrosis and the role of CFTR gene mutationsHum Genet, 93
-
C. Scriver, P. Waters (1999)
Monogenic traits are not simple: lessons from phenylketonuria.Trends in genetics : TIG, 15 7
-
Luca Tamagnone, I. Lahtinen, T. Mustonen, K. Virtaneva, Fiona Francis, Françoise Muscatelli, R. Alitalo, C. Smith, C. Larsson, Kari Alitalo (1994)
BMX, a novel nonreceptor tyrosine kinase gene of the BTK/ITK/TEC/TXK family located in chromosome Xp22.2.Oncogene, 9 12
-
Eric Fearon, Jerry Winkelstein, Curt Civin, Drew Pardoll, Bert Vogelstein (1987)
Carrier detection in X-linked agammaglobulinemia by analysis of X-chromosome inactivation.The New England journal of medicine, 316 8
-
J. Bolen (1993)
Nonreceptor tyrosine protein kinases.Oncogene, 8 8
-
Goddard Ea, Beatty Dw (1989)
X-linked agammaglobulinaemia.South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 76 11
-
P. Sideras, C. Smith (1995)
Molecular and cellular aspects of X-linked agammaglobulinemia.Advances in immunology, 59
-
O. Racchi, R. Mangerini, D. Rapezzi, M. Rolfo, G. Gaetani, A. Ferraris (1998)
X chromosome inactivation patterns in normal females.Blood cells, molecules & diseases, 24 4
-
J. Puck (1994)
Molecular basis for three X-linked immune disorders.Human molecular genetics, 3 Spec No
-
Tracy Hagemann, F. Rosen, S. Kwan (1995)
Characterization of germline mutations of the gene encoding Bruton's tyrosine kinase in families with X‐linked agammaglobulinemiaHuman Mutation, 5
-
P. Mattsson, I. Lappalainen, C. Bäckesjö, E. Brockmann, Susanna Laurén, M. Vihinen, C. Smith (2000)
Six X-Linked Agammaglobulinemia-Causing Missense Mutations in the Src Homology 2 Domain of Bruton’s Tyrosine Kinase: Phosphotyrosine-Binding and Circular Dichroism Analysis1The Journal of Immunology, 164
-
H. Ochs, C. Smith (1996)
X-linked agammaglobulinemia. A clinical and molecular analysis.Medicine, 75 6
-
H. Mano, Kozue Mano, Bo Tang, Maria Koehler, T. Yi, D. Gilbert, Nancy Jenkins, N. Copeland, James Ihle (1993)
Expression of a novel form of Tec kinase in hematopoietic cells and mapping of the gene to chromosome 5 near Kit.Oncogene, 8 2
-
R. Haire, Y. Ohta, S. Strong, R. Litman, Y. Liu, J. Prchal, M. Cooper, G. Litman (1997)
Unusual patterns of exon skipping in Bruton tyrosine kinase are associated with mutations involving the intron 17 3' splice site.American journal of human genetics, 60 4
-
Igor Vorřechovský, L. Luo, J. Hertz, S. Frøland, T. Klemola, M. Fiorini, I. Quinti, R. Paganelli, H. Ozsahin, L. Hammarström, A. Webster, C. Smith (1997)
Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X‐linked agammaglobulinemiaHuman Mutation, 9
-
Michael Bykowsky, R. Haire, Yuko Ohta, Huayang Tang, Sun-Sang Sung, Ekaterina Veksler, Jeffrey Greene, Shu Fu, G. Litman, E. Kathleen, '. Sullivan (1996)
Discordant phenotype in siblings with X-linked agammaglobulinemia.American journal of human genetics, 58 3
-
Y. Ohta, R. Haire, R. Litman, S. Fu, R. Nelson, Jamie Kratz, S. Kornfeld, M. Morena, R. Good, G. Litman, G. Litman (1994)
Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia.Proceedings of the National Academy of Sciences of the United States of America, 91 19
-
M. Vihinen, Lennart Nilsson, C. Smith (1994)
Structural basis of SH2 domain mutations in X-linked agammaglobulinemia.Biochemical and biophysical research communications, 205 2
-
Elke Holinski-Feder, Michael Weiss, O. Brandau, KB Jedele, B. Nore, C. Bäckesjö, Mauno Vihinen, SR Hubbard, Bernd Belohradsky, C. Smith, A. Meindl (1998)
Mutation screening of the BTK gene in 56 families with X-linked agammaglobulinemia (XLA): 47 unique mutations without correlation to clinical course.Pediatrics, 101 2
-
Gáspár, Lester, Levinsky, Kinnon (1998)
Bruton's tyrosine kinase expression and activity in X‐linked agammaglobulinaemia (XLA): the use of protein analysis as a diagnostic indicator of XLAClinical & Experimental Immunology, 111
-
C. Bruun, Knut Sletten, G. Marhaug (1998)
Mouse serum amyloid A (SAA) proteins isolated by two‐dimensional electrophoresis: characterization of isotypes and the effect of separate and combined administrations of cytokines, dexamethasone and lipopolysaccharide (LPS) on serum levels and isotype distributionClinical & Experimental Immunology, 111
-
L. Bradley, A. Sweatman, R. Lovering, Alison Jones, G. Morgan, R. Levinsky, C. Kinnon (1994)
Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis.Human molecular genetics, 3 1
-
H. Jin, A. Webster, M. Vihinen, P. Sideras, I. Vořechovský, Lennart Hammarstrom, E. Bernatowska-Matuszkiewicz, C. Smith, M. Bobrow, D. Vetrie (1995)
Identification of Btk mutations in 20 unrelated patients with X-linked agammaglobulinaemia (XLA).Human molecular genetics, 4 4
-
K. Abernathy-Carver, A. Liu (1994)
THE GENE INVOLVED IN X-LINKED AGAMMAGLOBULINEMIA IS A MEMBER OF THE SRC FAMILY OF PROTEIN-TYROSINE KINASESPediatrics
-
K. Ritis, M. Speletas, V. Tsironidou, E. Pardali, M. Kanariou, V. Moschese, P. Orlandi, M. Skordala, P. Rossi, G. Kartalis, G. Bourikas, P. Sideras (1998)
Absence of Bruton's tyrosine kinase (Btk) mutations in patients with acute myeloid leukaemiaBritish Journal of Haematology, 102
-
S. Hashimoto, Satoshi Tsukada, M. Matsushita, Toshio Miyawaki, Y. Niida, A. Yachie, Shigeru Kobayashi, T. Iwata, H. Hayakawa, Hiroto Matsuoka, I. Tsuge, T. Yamadori, T. Kunikata, S. Arai, Kazuyuki Yoshizaki, Nobuhiro Taniguchi, T. Kishimoto (1996)
Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan.Blood, 88 2
-
T. Pawson (1997)
New impressions of Src and HckNature, 385
-
Paola Orlandi, K. Ritis, V. Moschese, F. Angelini, K. Arvanitidis, M. Speletas, P. Sideras, A. Plebani, P. Rossi (2000)
Identification of nine novel mutations in the Bruton's tyrosine kinase gene in X‐linked agammaglobulinaemia patientsHuman Mutation, 15
-
M. Conley, M. Conley, Derrick Mathias, Jason Treadaway, Yoshiyuki Minegishi, J. Rohrer (1998)
Mutations in btk in patients with presumed X-linked agammaglobulinemia.American journal of human genetics, 62 5
- Publisher
- Wiley
- Copyright
- Copyright © 2001 Wiley Subscription Services
- ISSN
- 0300-9475
- eISSN
- 1365-3083
- DOI
- 10.1046/j.1365-3083.2001.00967.x
- Publisher site
- See Article on Publisher Site
Abstract
Bruton's tyrosine kinase (Btk) is a nonreceptor tyrosine kinase, critical for B‐cell development and function. Mutations that inactivate this kinase were found in families with X‐linked agammaglobulinaemia (XLA). In this study the Btk gene was analyzed in 13 registered Greek patients with XLA phenotype originated from 12 unrelated families, in order to provide a definite diagnosis of the XLA. The structure of Btk was analyzed at the cDNA level using the recently developed method, NIRCA (Non‐Isotopic‐Rnase‐Cleavage‐Assay). Alterations were detected in all patients and sequencing analysis confirmed the results and defined six novel XLA‐associated Btk mutations (three missense mutations: C337G, L346R, L452P; one nonsense mutation: Y392X, and two frameshift alterations: c1211–1212delA, c1306–1307insA). Having defined the genetic alteration in the affected males of these families, the information was used to design polymerase chain reaction (PCR) primers and the Btk segments containing the mutated sequences were amplified from peripheral blood derived genomic DNA of potential female carriers. The PCR products were directly sequenced and carrier status was determined in 12 out of 16 phenotypically normal females analyzed. This protocol can be used once the nature of the Btk mutation has been defined in one of the affected males and provides a convenient, simple and reliable way to determine the carrier status of other female family members. Molecular genetic analysis constitutes a determinative tool for the definitive diagnosis of XLA and may allow accurate carrier and prenatal diagnosis for genetic counselling.
Journal
Scandinavian Journal of Immunology – Wiley
Published: Jan 1, 2001